Abstract
N-aryltriazole nucleosides are new chemical entities with potential biological activity. The two phosphor ligands, Synphos and Xantphos, had a selective and effective impact on Pd-catalyzed C-N coupling with the 5- and 3-bromotriazole acyclonucleoside isomers, affording the corresponding and otherwise difficult to achieve N-aryltriazole nucleosides with good to excellent yields. In addition, two of the synthesized nucleosides showed superior anticancer activity against drug-resistant pancreatic cancer, compared to the reference drug gemcitabine.
| Original language | English |
|---|---|
| Pages (from-to) | 5712-5715 |
| Number of pages | 4 |
| Journal | Organic Letters |
| Volume | 12 |
| Issue number | 24 |
| DOIs | |
| State | Published - 17 Dec 2010 |
Funding
We acknowledge financial support from the National Mega Project on Major Drug Development (2009ZX09301-014), Wuhan University, CNRS and INSERM. We thank Dr. Sandrine Henri for the help with radioactivity experiments. Dr. Yi Xia is supported by la Fondation pour la Recherche Medicale.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Indexed by
- SCIE
- Scopus
Fingerprint
Dive into the research topics of 'Ligand-Mediated Highly Effective and Selective C-N Coupling for Synthesizing Bioactive N-Aryltriazole Acyclonucleosides'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver